You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
Baselious F, Hilscher S, Robaa D, et al. (2024) Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor. International Journal of Molecular Sciences. 25 |
Pannek M, Alhalabi Z, Tomaselli D, et al. (2024) Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity. Journal of Medicinal Chemistry |
Tavares MT, Krüger A, Yan SLR, et al. (2023) 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports. 13: 21006 |
Baselious F, Robaa D, Sippl W. (2023) Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study. Computers in Biology and Medicine. 167: 107700 |
Abdelsalam M, Zmyslia M, Schmidtkunz K, et al. (2023) Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells. Archiv Der Pharmazie. e2300536 |
Sinatra L, Vogelmann A, Friedrich F, et al. (2023) Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation. Journal of Medicinal Chemistry. 66: 14787-14814 |
Bülbül EF, Robaa D, Sun P, et al. (2023) Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. Pharmaceuticals (Basel, Switzerland). 16 |
Wimmer S, Hoff K, Martin B, et al. (2022) Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors. Bioorganic Chemistry. 131: 106331 |
Darwish S, Heimburg T, Ridinger J, et al. (2022) Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras. Methods in Molecular Biology (Clifton, N.J.). 2589: 179-193 |
Abdelsalam M, Ibrahim HS, Krauss L, et al. (2022) Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell Lines. Methods in Molecular Biology (Clifton, N.J.). 2589: 145-155 |